These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23133815)

  • 1. Efficacy of (99m)Tc-EDDA/HYNIC-TOC SPECT/CT scintigraphy in Graves' ophthalmopathy.
    Zhao R; Wang J; Deng J; Yang W; Wang J
    Am J Nucl Med Mol Imaging; 2012; 2(2):242-7. PubMed ID: 23133815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (99m)Tc-HYNIC-TOC scintigraphy in evaluation of active Graves' ophthalmopathy (GO).
    Sun H; Jiang XF; Wang S; Chen HY; Sun J; Li PY; Ning G; Zhao YJ
    Endocrine; 2007 Jun; 31(3):305-10. PubMed ID: 17906380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves' disease.
    Burggasser G; Hurtl I; Hauff W; Lukas J; Greifeneder M; Heydari B; Thaler A; Wedrich A; Virgolini I
    J Nucl Med; 2003 Oct; 44(10):1547-55. PubMed ID: 14530465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
    Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma.
    Czepczyński R; Parisella MG; Kosowicz J; Mikołajczak R; Ziemnicka K; Gryczyńska M; Sowiński J; Signore A
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1635-45. PubMed ID: 17530247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.
    Trogrlic M; Tezak S
    Nucl Med Rev Cent East Eur; 2016; 19(2):74-80. PubMed ID: 27479884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Tc-99m polyclonal human immunoglobulin G scintigraphy in Graves' ophthalmopathy.
    Ortapamuk H; Hoşal B; Naldöken S
    Ann Nucl Med; 2002 Nov; 16(7):461-5. PubMed ID: 12508836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of
    Szumowski P; Abdelrazek S; Żukowski Ł; Mojsak M; Sykała M; Siewko K; Maliszewska K; Popławska-Kita A; Myśliwiec J
    BMC Endocr Disord; 2019 Jan; 19(1):10. PubMed ID: 30658624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc(V)-DMSA SPECT for the assessment of disease activity in Graves' ophthalmopathy.
    Reyhan M; Toygar O; Sukan A; Seydaoglu G; Bakiner OS; Aydin M; Yapar AF; Aktas A
    Nucl Med Commun; 2007 Oct; 28(10):775-81. PubMed ID: 17728607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental value of
    Trogrlic M; Težak S
    Nuklearmedizin; 2017 Jun; 56(3):97-107. PubMed ID: 28164207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Multi-Parameters Combination of Technetium-99m-Diethylene-Triamine-Pentaacetate Orbital Single-Photon Emission Computed Tomography/Computed Tomography for the Evaluation of Graves' Orbitopathy Activity.
    Sun L; Peng R; Sun R
    Semin Ophthalmol; 2024 Jul; 39(5):387-393. PubMed ID: 38411131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tc-99m polyclonal human immunoglobulin G imaging in Graves' ophthalmopathy.
    Durak H; Söylev M; Durak I; Değirmenci B; Capa Kaya G; Uysal B
    Clin Nucl Med; 2000 Sep; 25(9):704-7. PubMed ID: 10983759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical indications to the use of (99m)Tc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors.
    Parisella MG; Chianelli M; D'Alessandria C; Todino V; Mikolajczak R; Papini E; Dierckx RA; Scopinaro F; Signore A
    Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):90-8. PubMed ID: 21068709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrobulbar 99mTc-diethylenetriamine-pentaacetic-acid uptake may predict the effectiveness of immunosuppressive therapy in Graves' ophthalmopathy.
    Ujhelyi B; Erdei A; Galuska L; Varga J; Szabados L; Balazs E; Bodor M; Cseke B; Karanyi Z; Leovey A; Mezosi E; Burman KD; Berta A; Nagy EV
    Thyroid; 2009 Apr; 19(4):375-80. PubMed ID: 19355827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
    Gabriel M; Decristoforo C; Donnemiller E; Ulmer H; Watfah Rychlinski C; Mather SJ; Moncayo R
    J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptor scintigraphy in patients with rheumatoid arthritis and secondary Sjögren's syndrome treated with Infliximab: a pilot study.
    Anzola-Fuentes LK; Chianelli M; Galli F; Glaudemans AW; Martin Martin L; Todino V; Migliore A; Signore A
    EJNMMI Res; 2016 Dec; 6(1):49. PubMed ID: 27259576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of
    Li B; Duan L; Li X; Shi J; Li H; Liu H; Cheng X; Wu X; Gao Y
    Front Oncol; 2023; 13():1228575. PubMed ID: 37554164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
    Kosowicz J; Mikołajczak R; Czepczyński R; Ziemnicka K; Gryczyńska M; Sowiński J
    Cancer Biother Radiopharm; 2007 Oct; 22(5):613-28. PubMed ID: 17979564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy.
    Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B
    Thyroid; 2002 Jul; 12(7):603-8. PubMed ID: 12193305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of disease activity in Graves' orbitopathy with different methods: comparison of (99m)Tc-DTPA and (99m)Tc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores.
    Galuska L; Leovey A; Szucs-Farkas Z; Szabados L; Garai I; Berta A; Balazs E; Varga J; Nagy EV
    Nucl Med Commun; 2005 May; 26(5):407-14. PubMed ID: 15838422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.